Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis.

Solomon BD, Mueller C, Chae WJ, Alabanza LM, Bynoe MS.

Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2040-5. doi: 10.1073/pnas.1008721108. Epub 2011 Jan 18.

2.

Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.

Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.

Tohoku J Exp Med. 2007 Dec;213(4):329-39.

3.

IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.

Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL.

Int Immunol. 2004 Feb;16(2):249-56.

4.

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.

Benkhoucha M, Santiago-Raber ML, Schneiter G, Chofflon M, Funakoshi H, Nakamura T, Lalive PH.

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6424-9. doi: 10.1073/pnas.0912437107. Epub 2010 Mar 23.

5.

Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.

Zhang GX, Yu S, Gran B, Li J, Siglienti I, Chen X, Calida D, Ventura E, Kamoun M, Rostami A.

J Immunol. 2003 Nov 1;171(9):4485-92.

6.

Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.

Mangalam AK, Luckey D, Giri S, Smart M, Pease LR, Rodriguez M, David CS.

J Autoimmun. 2012 Jun;38(4):344-53. doi: 10.1016/j.jaut.2012.02.004. Epub 2012 Mar 28.

9.

Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.

Batoulis H, Addicks K, Kuerten S.

Ann Anat. 2010 Aug 20;192(4):179-93. doi: 10.1016/j.aanat.2010.06.006. Epub 2010 Jul 15. Review. Erratum in: Ann Anat. 2011 Feb 20;193(1):76-7.

PMID:
20692821
10.

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10.

Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC.

Int Immunol. 1999 Oct;11(10):1625-34.

12.

T-bet is essential for the progression of experimental autoimmune encephalomyelitis.

Nath N, Prasad R, Giri S, Singh AK, Singh I.

Immunology. 2006 Jul;118(3):384-91.

15.

CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.

Rojo JM, Pini E, Ojeda G, Bello R, Dong C, Flavell RA, Dianzani U, Portolés P.

Int Immunol. 2008 Apr;20(4):577-89. doi: 10.1093/intimm/dxn016. Epub 2008 Feb 28.

17.

Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.

Dai H, Ciric B, Zhang GX, Rostami A.

J Neuroimmunol. 2012 Apr;245(1-2):1-7. doi: 10.1016/j.jneuroim.2012.01.005. Epub 2012 Feb 25.

18.

Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.

Bischof F, Hofmann M, Schumacher TN, Vyth-Dreese FA, Weissert R, Schild H, Kruisbeek AM, Melms A.

J Immunol. 2004 Mar 1;172(5):2878-84.

19.
20.

Regulatory T cells in spontaneous autoimmune encephalomyelitis.

Furtado GC, Olivares-Villagómez D, Curotto de Lafaille MA, Wensky AK, Latkowski JA, Lafaille JJ.

Immunol Rev. 2001 Aug;182:122-34. Review.

PMID:
11722629
Items per page

Supplemental Content

Write to the Help Desk